abnormal lipid level_Sgms2<tm1Jia>/Sgms2<tm1Jia>

http://metadb.riken.jp/0001547I129C57BL6Sgms2tm1JiaSgms2tm1JiaSgms2tm1Jia

abnormal lipid level_Sgms2<tm1Jia>/Sgms2<tm1Jia>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• sphingomyelin synthase 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:1921692

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Sgms2<tm1Jia>/Sgms2<tm1Jia>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Sgms2<tm1Jia>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129 * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal lipid level
  http://purl.obolibrary.org/obo/MP_0001547

文献

http://purl.org/net/cito/citesAsAuthority

• Jing. Liu, et.al., Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice., Arteriosclerosis, thrombosis, and vascular biology, 2009, 29
  http://rdf.ncbi.nlm.nih.gov/pubmed/19286635
• Tiruneh K. Hailemariam, et.al., Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation., Arteriosclerosis, thrombosis, and vascular biology, 2008, 28
  http://rdf.ncbi.nlm.nih.gov/pubmed/18566297